ATE131533T1 - Diagnostika und impfstoffe für mycobacteria in der volksgesundheit, in der medizinischen und veterinären praxis - Google Patents

Diagnostika und impfstoffe für mycobacteria in der volksgesundheit, in der medizinischen und veterinären praxis

Info

Publication number
ATE131533T1
ATE131533T1 AT88303657T AT88303657T ATE131533T1 AT E131533 T1 ATE131533 T1 AT E131533T1 AT 88303657 T AT88303657 T AT 88303657T AT 88303657 T AT88303657 T AT 88303657T AT E131533 T1 ATE131533 T1 AT E131533T1
Authority
AT
Austria
Prior art keywords
mycobacteria
vaccines
ism
probes
diagnostics
Prior art date
Application number
AT88303657T
Other languages
English (en)
Inventor
John Dept Of Sur Hermon-Taylor
Medical School Hospital
John-Jo Dept Of Surge Mcfadden
School Medical
Original Assignee
Bioscience Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioscience Int Inc filed Critical Bioscience Int Inc
Application granted granted Critical
Publication of ATE131533T1 publication Critical patent/ATE131533T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88303657T 1987-04-24 1988-04-22 Diagnostika und impfstoffe für mycobacteria in der volksgesundheit, in der medizinischen und veterinären praxis ATE131533T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878709803A GB8709803D0 (en) 1987-04-24 1987-04-24 Treatment of crohn's disease &c

Publications (1)

Publication Number Publication Date
ATE131533T1 true ATE131533T1 (de) 1995-12-15

Family

ID=10616336

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88303657T ATE131533T1 (de) 1987-04-24 1988-04-22 Diagnostika und impfstoffe für mycobacteria in der volksgesundheit, in der medizinischen und veterinären praxis

Country Status (11)

Country Link
EP (2) EP0288306B1 (de)
JP (1) JPH03503837A (de)
AT (1) ATE131533T1 (de)
AU (1) AU624574B2 (de)
CA (1) CA1340172C (de)
DE (1) DE3854767T2 (de)
DK (1) DK524289A (de)
FI (1) FI895050A7 (de)
GB (1) GB8709803D0 (de)
NZ (1) NZ224351A (de)
WO (1) WO1988008456A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US4918178A (en) * 1987-10-22 1990-04-17 Wisconsin Alumni Research Foundation Test for Johne's disease
CA1339260C (en) * 1988-06-02 1997-08-12 Kazumi Kodama Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
CA2016553A1 (en) * 1989-05-16 1990-11-16 Dyann F. Wirth Dna hybridization probes for identification of mycobacteria
FR2651505B1 (fr) * 1989-09-06 1994-07-22 Pasteur Institut Fragments d'acides nucleiques derives d'un genome de mycobacterie appropriee, leurs applications dans le diagnostic des infections a mycobacteries et plasmides contenant lesdits fragments.
DK0490951T3 (da) * 1989-09-06 1996-08-26 Pasteur Institut Nucleinsyrefragmenter fra en genom fra en egnet mycobakterie, deres anvendelse til diagnose af mycobakterieinfektioner samt plasmider indeholdende disse fragmenter
EP0419355B1 (de) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose
US7083797B2 (en) 1990-09-19 2006-08-01 N.V. Innogenetics S.A. 32-kDa protein derived from Mycobacterium tuberculosis and related peptides
JP2756368B2 (ja) 1989-09-19 1998-05-25 エヌ・ブイ・インノジェネティクス・ソシエテ・アノニム 組換えポリペプチド及びペプチド、それをコードする核酸並びに結核の診断におけるこれらのポリペプチド及びペプチドの使用
NZ231429A (en) * 1989-11-17 1992-12-23 Univ Massey Diagnostic probes and their use in detecting mycobacterium paratuberculosis
US5174983A (en) * 1990-09-24 1992-12-29 The United States Of America, As Represented By The Secretary Of The Navy Flame or plasma synthesis of diamond under turbulent and transition flow conditions
US5168039A (en) * 1990-09-28 1992-12-01 The Board Of Trustees Of The University Of Arkansas Repetitive DNA sequence specific for mycobacterium tuberculosis to be used for the diagnosis of tuberculosis
WO1992016628A1 (en) * 1991-03-25 1992-10-01 N.V. Innogenetics S.A. Polypeptides from mycobacterium paratuberculosis
FR2682967B1 (fr) * 1991-10-25 1994-01-14 Pasteur Institut Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques.
FR2683227B1 (fr) * 1991-10-31 1994-03-04 Pasteur Institut Sequences nucleotidiques hybridant avec les souches bacteriennes du complexe mycobacterium avium-intracellulare, leur utilisation comme amorces oligonucleotidiques et sondes nucleiques.
US5314801A (en) * 1992-11-06 1994-05-24 Becton, Dickinson And Company Probes to Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium paratuberculosis
GB9526178D0 (en) 1995-12-21 1996-02-21 Taylor John Hermon Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy
DE19728834C2 (de) * 1997-07-05 1999-10-21 Gerlach Gerald F Eisenreduktase
GB9806093D0 (en) * 1998-03-20 1998-05-20 Taylor John Hermon Diagnostics and vaccines for mycobacterial infections of animals and humans
US20050232937A1 (en) * 2002-01-11 2005-10-20 Willemsen Petrus Theodorus J Paramycobacterial diagnostics and vaccines
NZ519469A (en) * 2002-06-10 2005-01-28 Agres Ltd Nucleic acid probes for detecting the presence of Mycobacterium paratuberculosis and distinguishing between cattle and sheep strains
DE10309368A1 (de) * 2002-08-06 2004-02-26 Aventis Behring Gmbh Intellectual Property/Legal Pharmazeutische Zubereitung mit RNA als Cofaktor der Hämostase
AU2006277828B2 (en) 2005-08-09 2012-02-02 Hav Vaccines Limited Immunogenic constructs
DE102012103730A1 (de) 2012-04-27 2013-11-14 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Nachweisverfahren für Mycobacterium avium ssp. paratuberculosis
GB201700487D0 (en) 2017-01-11 2017-02-22 Hermon-Taylor John Diagnostic
GB201811382D0 (en) 2018-07-11 2018-08-29 Taylor John Hermon Vaccine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717653A (en) * 1981-09-25 1988-01-05 Webster John A Jr Method for identifying and characterizing organisms
FI63596C (fi) * 1981-10-16 1983-07-11 Orion Yhtymae Oy Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
ATE202801T1 (de) * 1983-01-10 2001-07-15 Gen Probe Inc Verfahren zum nachweis, identifizieren und quantifizieren von organismen und viren
CA1277931C (en) * 1984-06-05 1990-12-18 Shimon Ulitzur Detection and/or identification of microorganisms in a test sample usingbioluminescence or other exogenous genetically-introduced marker
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4755458A (en) * 1984-08-30 1988-07-05 Enzo Biochem, Inc. Composition and method for the detection of the presence of a polynucleotide sequence of interest
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
DE3687645T2 (de) * 1986-01-07 1993-05-27 Gen Probe Inc Verfahren der beschleunigten wiederassoziation der nukleinsaeure.
DE3627475A1 (de) * 1986-06-26 1988-01-14 Gergely Gerhard Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
JPH01503753A (ja) * 1986-07-25 1989-12-21 サイナーゲン，インコーポレーテッド 豚のマイコプラズマ感染診断に有用なポリペプチド及びそれを製造するための組換えｄｎａ法
US4906742A (en) * 1986-07-31 1990-03-06 Whitehead Institute For Biomedical Research Encoding antigens of M. Leprae
WO1988003957A1 (en) * 1986-11-24 1988-06-02 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms

Also Published As

Publication number Publication date
AU624574B2 (en) 1992-06-18
DE3854767T2 (de) 1996-09-05
FI895050A0 (fi) 1989-10-24
DK524289D0 (da) 1989-10-23
NZ224351A (en) 1990-12-21
EP0288306B1 (de) 1995-12-13
DE3854767D1 (de) 1996-01-25
JPH03503837A (ja) 1991-08-29
CA1340172C (en) 1998-12-08
AU1628688A (en) 1988-12-02
EP0288306A1 (de) 1988-10-26
WO1988008456A1 (en) 1988-11-03
DK524289A (da) 1989-12-22
GB8709803D0 (en) 1987-05-28
FI895050A7 (fi) 1989-10-24
EP0356450A1 (de) 1990-03-07

Similar Documents

Publication Publication Date Title
ATE131533T1 (de) Diagnostika und impfstoffe für mycobacteria in der volksgesundheit, in der medizinischen und veterinären praxis
Stiernstedt et al. Clinical manifestations and diagnosis of neuroborreliosis
ATE530671T1 (de) Verbindungen und verfahren zur diagnose von tuberkulose
Collins et al. Diagnosis and epidemiology of bovine tuberculosis using molecular biological approaches
ATE469222T1 (de) Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
DE60016275T2 (de) Helicobacter pylori antigene in blut
BR0112602A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
HUP0203705A2 (hu) Vegyületek és eljárások Chlamydia-fertőzés kezelésére és diagnózisára
DE69232956D1 (de) Verbesserungen der diagnose und der prophylaxe von borrelia burgdorferi
DE60133190D1 (de) Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
ATE127530T1 (de) Universelle nukleinsäuresonden für eubakterien sowie methoden.
DE69230148D1 (de) Werkzeuge für die Diagnose und Behandlung der Alzheimerschen Krankheit.
DE69115926D1 (de) Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
Schmidt et al. Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy
KR100951057B1 (ko) 면역특이단백질 항원을 사용하는 우결핵 특이 효소면역진단키트 및 이를 이용한 우결핵 진단방법
Scanziani et al. Serological findings in cases of acute leptospirosis in the dog
Hässig et al. Relationship between abortions and seroprevalences to selected infectious agents in dairy cows
Shrivastaw et al. Quantitation of protein content by biuret method during production of yellow fever vaccine
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
DE69331377D1 (de) Verfahren und zusammensetzungen zur diagnose der katzenkratzkrankheit und der bakteriellen angiomatose
Steadham et al. Production of a Mycobacterium avium ssp. paratuberculosis purified protein derivative (PPD) and evaluation of potency in guinea pigs
ATE382678T1 (de) Verfahren zur diagnose von rickettsia pulicis
CN105388300A (zh) 结核病免疫诊断分子标识及其疫苗用途
Black et al. Distinguishing Chlamydia species by restriction analysis of the major outer membrane protein gene
DE69535156D1 (de) Verfahren und zusammensetzungen zur diagnose von rochalimaea henselae und rochalimaea quintana infektion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties